A biological model for the regulation of peri-implantation hemostasis and menstruation

Journal of the Society for Gynecologic Investigation

Volumn 3, Issue 4, 1996, Pages 159-165

  Lockwood, Charles J ^a   Schatz, Frederick ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endometrium; hemostasis; trophoblast invasion

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

DECIDUALIZATION; ENDOMETRIUM; FEMALE; HEMOSTASIS; HORMONAL REGULATION; HUMAN; MENSTRUATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STROMA CELL; TROPHOBLAST;

EMBRYO IMPLANTATION; ENDOMETRIUM; ENDOTHELINS; ESTROGENS; FEMALE; FIBRINOLYSIS; GENE EXPRESSION; HEMOSTASIS; HOMEOSTASIS; HUMANS; MENSTRUATION; METALLOENDOPEPTIDASES; MODELS, BIOLOGICAL; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNANCY; PROGESTINS; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; TROPHOBLASTS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0030200555     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/1071-5576(96)00005-6     Document Type: Review

References (79)

1. 1. Knight C. Blood relations. New Haven, Connecticut: Yale University Press, 1991.
2. 2. Profet M. Menstruation as a defense against pathogens transported by sperm. Q Rev Biol 1993;68:335-86.
3. 3. Moore KL. The developing human. 4th ed. Philadelphia: WB Saunders, 1988:40.
4. 4. De Wolf F, De Wolf-Peeters C, Brosens I. Ultrastructure of the spiral arteries in the human placental bed at the end of normal pregnancy. Am J Obstet Gynecol 1973;117:833-48.
5. 5. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950;1:3-25.
6. 6. Bell SC. Decidualization and relevance to menstruation. In: D'Arcangues C, Fraser IS, Newton JR, Odlind V, eds. Contraception and mechanisms of endometrial bleeding. Cambridge, United Kingdom: Cambridge University Press, 1990:188.
7. 7. Ramsey EM, Houston ML, Harris JW. Interactions of the trophoblast and maternal tissues in three closely related primate species. Am J Obstet Gynecol 1976;124:647-52.
8. 8. Finn CA. Why do women and some other primates menstruate? Perspect Biol Med 1987;30:566-74.
9. 9. Littlefield BA. Plasminogen activators in endometrial physiology and embryo implantation: A review. Ann N Y Acad Sci 1991; 622:167-75.
10. 10. Rodgers WH, Matrisian LM, Giudice LC, et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest 1994;94:946-53.
11. 11. Lockwood CJ, Krikun G, Papp C, et al. The role of progestationally regulated stromal cell tissue factor and type-1 plasminogen activator inhibitor (PAI-1) in endometrial hemostasis and menstruation. Ann N Y Acad Sci 1994;734:57-79.
12. 12. Lockwood CJ, Nemerson Y, Guller S, et al. Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J Clin Endocrinol Metab 1993;76:231-6.
13. 13. Huang JR, Tseng L, Bischof P, Janne OA. Regulation of prolactin production by progestin, estrogen, and relaxin in human endometrial stromal cells. Endocrinology 1987;121:2011-7.
14. 14. Irwin JC, Kirk D, King RJ, Quigley MM, Gwatkin RB. Hormonal regulation of human endometrial stromal cells in culture: An in vitro model for decidualization. Fertil Steril 1989;52:761-68.
15. 15. Zhu HH, Huang JR, Mazella J, Elias J, Tseng L. Progestin stimulates the biosynthesis of fibronectin and accumulation of fibronectin mRNA into human endometrial stromal cells. Hum Reprod 1992;7:141-146.
16. 16. Bell SC, Jackson JA, Ashmore J, Zhu HH, Tseng L. Regulation of insulin-like growth factor binding protein-1 synthesis and secretion by progestin and relaxin in long term cultures of human endometrial stromal cells. J Clin Endocrinol Metab 1991;72: 1014-24.
17. 17. Giudice LK, Milkowski DA, Lamson G, Rosenfield RG, Irwin JC. Insulin-like growth factor binding proteins in human endometrium: Steroid-dependent messenger ribonucleic acid expression and protein synthesis. J Clin Endocrinol Metab 1991;72: 779-87.
18. 18. Casslen B, Urano S, Lecander I, Ny T. Plasminogen activators in the human endometrium, cellular origin and hormonal regulation. Blood Coagul Fibrinolysis 1992;3:133-8.
19. 19. Schatz F, Aigner S, Papp C, Toth-Pal E, Hausknecht V, Lockwood CJ. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1. J Clin Endocrinol Metab 1995;80:2504-10.
20. 20. Schatz F, Papp C, Toth-Pal E, Lockwood CJ. Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells. J Clin Endocrinol Metab 1994;78:1467-72.
21. 21. Osteen KG, Rodgers WH, Gaire M, Hargrove JT, Gorstein F, Matrisian LM. Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci U S A 1994;91:10129-33.
22. 22. Casslen B, Urano S, Ny T. Progesterone regulation of plasminogen activator inhibitor 1 (PAI-1) antigen and mRNA levels in human endometrial stromal cells. Thromb Res 1992;66:75-87.
23. 23. Schatz F, Lockwood CJ. Progestin regulation of plasminogen activator inhibitor type-1 in primary cultures of endometrial stromal and decidual cells. J Clin Endocrinol Metab 1993;77:621-625.
24. 24. Lockwood CJ, Nemerson Y, Krikun G, et al. Steroid-modulated stromal cell tissue factor expression: a model for the regulation of endometrial hemostasis and menstruation. J Clin Endocrinol Metab 1993;77:1014-9.
25. 25. Lubbert H, Pollow K, Rommler A, Hammerstein J. Estradiol and progesterone receptor concentrations and 17β-hydroxysteroid-dehydrogenase activity in estrogen-progestin stimulated endometrium of women with gonadal dysgenesis. J Steroid Biochem 1982;17:143-8.
26. 26. Eckert RL, Katzenellenbogen BS. Human endometrial cells in primary tissue culture: Modulation of the progesterone receptor levels by natural and synthetic estrogens in vitro. J Clin Endocrinol Metab 1981;52:699-708.
27. 27. Zini JM, Murray SC, Graham CH, et al. Characterization of urokinase receptor expression by human placental trophoblasts. Blood 1992;79:2917-29.
28. 28. Strickland S, Richards WG. Invasion of the trophoblasts. Cell 1992;71:355-7.
29. 29. Feinberg RF, Kao LC, Haimowitz JE, et al. Plasminogen activator types 1 and 2 in human trophoblasts: PAI-1 is an immunocytochemical marker of invading trophoblasts. Lab Invest 1989;61:20-6.
30. 30. Vaselli JD, Sappino AP, Belin D. The plasminogen activator/ plasmin system. J Clin Invest 1991;88:1067-72.
31. 31. Nermerson Y. Tissue factor and hemostasis. Blood 1988;71:1-8.
32. 32. Gelehrter TD, Sznycer-Laszuk R. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. J Clin Invest 1986;77:160-5.
33. 33. Hinsbergh VWM, Sprengers ED, Kooistra T. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin micro vascular endothelial cells. Thromb Haemost 1987;57:148-53.
34. 34. Librach CL, Werb Z, Fitzgerald ML, et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblast cells in vitro. J Cell Biol 1991;113:437-49.
35. 35. He Cs, Wilhelm SM, Pentland AP, et al. Tissue cooperativity in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci U S A 1989;86:2632-6.
36. 36. Ogata Y, Enghild JJ, Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 1992;267:3581-4.
37. 37. Graham CH, Lala PK. Mechanism of control of trophoblast invasion in situ. J Cell Physiol 1991;148:228-34.
38. 38. Casslen B, Astedt B. Fibrinolytic activity of human uterine fluid. Acta Obstet Gynecol Scand 1981;60:55-8.
39. 39. Gleeson NC. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia. Am J Obstet Gynecol 1994;171:178-83.
40. 40. Lockwood CJ, Krikun G, Papp C, Aigner S, Nemerson Y, Schatz F. Biological mechanisms underlying RU 486 clinical effects: Inhibition of endometrial stromal cell tissue factor content. J Clin Endocrinol Metab 1994;79:786-90.
41. 41. Lockwood CJ, Krikun G, Papp C, Aigner S, Schatz F. Biological mechanisms underlying RU 486 clinical effects: Modulation of endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression. J Clin Endocrinol Metab 1995;80: 1100-5.
42. 42. Markee JE. Morphological basis for menstrual bleeding. Bull N Y Acad Med 1948;24:253-68.
43. 43. Lack CH, Rogers HJ. Action of plasmin on cartilage. Nature 1958;182:948.
44. 44. Mullin DE, Rorlich ST. The role of proteinases in cellular invasiveness. Biochim Biophys Acta 1983;695:177-214.
45. 45. O'Grady RL, Upfold LI, Stephens RW. Rat mammary carcinoma cells secrete active collagenase and active latent enzymes in the stroma via plasminogen activator. Int J Cancer 1981;28: 509-15.
46. 46. Tryggvason K, Hoyhtya M, Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 1987;907:191-217.
47. 47. Werb A, Maiardi CL, Vater CA, Harris ED Jr. Endogenous activation of latent collagenases by rheumatoid synovial cells: Evidence for a role of plasminogen activator. N Engl J Med 1977;296:1017.
48. 48. Casey ML, MacDonald PC. Modulation of endometrial blood flow: Regulation of endothelin-1 biosynthesis and degradation in human endometrium. Steroid hormones and uterine bleeding. In: Alexander NJ, d'Arcangues C, eds. Washington, DC: AAAS Press, 1992:209.
49. 49. Wiqvist N, Bygdeman M, Kirton K: Non-steroidal antifertility agents in the female. Nobel symposium 15: Control of human fertility. In: Diczfalusy E, Borell U, eds. Stockholm: Almquist & Wiksell Förlag AB, 1971:137-49.
50. 50. Toppozada MA, El-Attar A, El-Ayyat MS, Khamis Y. Management of uterine bleeding by PGs or their synthesis inhibitors. Adv Prostaglandin Thromboxane Res 1980;8:1459-63.
51. 51. Karim SMM. Clinical applications of prostaglandins in obstetrics and gynaecology. In: Karim SMM, ed. Cervagem: A new prostaglandin in obstetrics and gynaecology. Lancaster: MTP Press, 1983:15-34.
52. 52. Chan WY, Dawood MY, Fuchs F. Relief of dysmenorrhoea with the prostaglandin synthase inhibitor ibuprofen: Effect of prostaglandin levels in menstrual fluid. Am J Obstet Gynecol 1979;135:102-8.
53. 53. Guillebaud J, Anderson ABM, Turnbull AC. Reduction of mefanamic acid of increased menstrual blood loss associated with intra-uterine contraception. Br J Obstet Gynaecol 1978;85:53-62.
54. 54. Smith SK. The physiology of menstruation. In: D'Arcangues C, Fraser IS, Newton JR, Odlind V, eds. Contraception and mechanisms of endometrial bleeding. Cambridge, United Kingdom: Cambridge University Press, 1989:33-56.
55. 55. Abel MH, Baird DT. The effect of 17β-estradiol and progesterone on prostaglandin production by endometrium maintained in organ culture. Endocrinology 1980;106:1599-606.
56. 56. Henzl MR, Smith RE, Boost G, Tyler ET. Lysosomal concept of menstrual bleeding in humans. J Clin Endocrinol Metab 1972; 34:860-70.
57. 1α production by cultured human endometrial and myometrial explants. Prostaglandins Leukot Med 1984;13:179-96.
58. 2α output by human endometrium and endometrial epithelial cells. J Clin Endocrinol Metab 1985;61:361-7.
59. 2α output by epithelial and stromal cells of human endometrium. Endocrinology 1987;120:1465-71.
60. 2 from separated cells of human endometrium and decidua. Prostaglandins Leukot Essent Fatty Acids 1988;33:91-6.
61. 2α production by human endometrium and endometrial epithelial cells. Endocrinology 1986;118:408-12.
62. 62. Cornillie FJ, Brosens IA, Marbaix E, Vael Th, Baudhuin P, Courtoy PJ. A biochemical study of lysosomal enzymes in control and levonorgestrel-treated human endometria: Analysis of total activity and evidence for secretion. In: D'Arcangues C, Fraser IS, Newton JR, Odlin V, eds. Contraception and mechanisms of endometriol bleeding. Cambridge, United Kingdom: Cambridge University Press, 1990:383.
63. 63. Lockwood CJ, Aigner S, Krikun G, Schatz F. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential. J Clin Endocrinol Metab 1996;81:107-12.
64. 64. Lockwood CJ, Nemerson Y, Krikun G, et al. Steroid-modulated stromal cell tissue factor expression: A model for the regulation of endometrial hemostasis and menstruation. J Clin Endocrinol Metab 1993;77:1014-9.
65. 65. Jackson CM. The biochemistry of prothrombin activation. In: Bloom AL, Thomas DP, eds. Haemostasis and thrombosis. 2nd ed. New York: Churchill Livingstone, 1987:165-91.
66. 66. Vu T-KH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991;64:1057-68.
67. 67. Carney DH, Redin W, McCroskey L. Role of high-affinity thrombin receptors in postclotting cellular effects of thrombin. Semin Thromb Hemost 1992;18:91-103.
68. 68. Hing SH. Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and human umbilical vein. Thromb Res 1980;18:787-95.
69. 69. Levin EG, Stern DM, Naworth PP, et al. Specificity of the thrombin-induced release of tissue plasminogen activator from cultured human endothelial cells. Thromb Haemost 1986;56: 115-19.
70. 70. Wojta J, Gallicchio M, Zoellner H, et al. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells. Thromb Haemost 1993;70:469-74.
71. 71. He C-J, Rondeau E, Medcalf RL, Lacave R, Schleuning WD, Sraer JD. Thrombin increases proliferation and decreases fibrinolytic activity of kidney glomerular epithelial cells. J Cell Physiol 1991;146:131-40.
72. 72. Zetter BR. Angiogenesis. State of the art. Chest 1988;93:159S-66S.
73. 73. Reynolds LP, Killilea SD, Redmer DA. Endometrial growth and vascular development: Patterns and mediators. In: Alexander NJ, d'Arcangues C, eds. Steroid hormones and uterine bleeding. Washington, DC: AAAS Press, 1992:37.
74. 74. Ferenczy A, Bertrand G, Gelfand MM. Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 1979;133:859-67.
75. 75. Hourihan HM, Sheppard BL, Belsey EM, Brosens IA. Endometrial vascular features prior to and following exposure to levonorgestrel. Contraception 1991;43:375-85.
76. 76. Rogers PAW, Au CL, Affandi B. Endometrial microvascular density during the normal menstrual cycle and immunochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab 1988;67:80-7.
77. 77. Goodger AM, Rogers PAW. Endometrial endothelial cell proliferation during the menstrual cycle. Hum Reprod 1994;9:399-405.
78. 78. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 1988;67:334-40.
79. 79. Snijders MPML, de Goeij AFPM, Debets-Te Baerts MJC, Rousch MJM, Koudstaal J, Bosman FT. Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause. J Reprod Fertil 1992;94:363-71.